Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Ca2+
-
Ca2+
2-3 mM is required for half-activation
Ca2+
2-4 mM is required for half-activation
additional information
-
domain III might be the primary lipid binding site of calpain and may play a decisive role in orchestrating Ca2+- and lipid activation of the enzyme
-
additional information
-
no activation by phosphatidylinositol 4,5-diphosphate, phosphatidylinositol 4-monophosphate, phosphatidylinositol or phosphatidic acid. N-terminal autolysis in a Ca2+-dependent manner which runs parallel with the enzyme activation
-
additional information
no activation by phosphatidylinositol 4,5-diphosphate, phosphatidylinositol 4-monophosphate, phosphatidylinositol or phosphatidic acid. N-terminal autolysis in a Ca2+-dependent manner which runs parallel with the enzyme activation
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
BIII-D613N/D614N
retains 30% of the wild-type Ca2+-binding capacity
BIII-D617N/D618
retains 60% of the wild-type Ca2+-binding capacity
BIII-E610A/D611A/P612A, delta613-620 deletion mutant
unable to bind Ca2+
BIII-E610Q/D611N/D613N/D614N
retains 16.2% of the wild-type Ca2+-binding capacity
BIII-E615Q/D616N/D617N/D618N
retains 36% of the wild-type Ca2+-binding capacity
BIII-P612A, delta613-620 deletion mutant
retains one-third of the original Ca2+- binding capacity
D613N/D614N
enhances specific activity to 114% of the wild-type activity
D617N/D618N
reduces specific activity to 66% of the wild-type activity
S845E
the mutation causes a small but reproducible increase in the activation of calpain B
T747E
the mutation causes a large increase in the activation of calpain B
Q73G/N74V/A75P/N223A/Q224V
-
mutation within the autolytic cleavage sites, autolysis is not arrested by the mutations but its site shifts to new, nearby peptide bonds. In the case of site between Q224 and N225, two new sites emerge: one at F215-T216 and one at G230-R231. In the case of site between N74 and A75, modification gives rise to low intensity, blurred bands which can not be analyzed by sequencing
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Boeckmann, B.; Bairoch, A.; Apweiler, R.; Blatter, M.C.; Estreicher, A.; Gasteiger, E.; Martin M.J.; Michoud, K.; O'Donovan, C.; Phan, I.; Pilbout, S.; Schneider, M.
The SWISS-PROT protein knowledgebase and its supplement TrEMBL
Nucleic Acids Res.
31
365-370
2003
Drosophila melanogaster (Q9VT65)
brenda
Jekely, G.; Friedrich, P.
Characterization of two recombinant Drosophila calpains. CALPA and a novel homolog, CALPB
J. Biol. Chem.
274
23893-23900
1999
Drosophila melanogaster, Drosophila melanogaster (Q9VT65)
brenda
Farkas, A.; Tompa, P.; Schad, E.; Sinka, R.; Jekely, G.; Friedrich, P.
Autolytic activation and localization in Schneider cells (S2) of calpain B from Drosophila
Biochem. J.
378
299-305
2003
Drosophila melanogaster
brenda
Tompa, P.; Emori, Y.; Sorimachi, H.; Suzuki, K.; Friedrich, P.
Domain III of calpain is a Ca2+-regulated phospholipid-binding domain
Biochem. Biophys. Res. Commun.
280
1333-1339
2001
Drosophila melanogaster
brenda
Friedrich, P.
The intriguing Ca2+ requirement of calpain activation
Biochem. Biophys. Res. Commun.
323
1131-1133
2004
Drosophila melanogaster (Q9VT65)
brenda
Friedrich, P.; Tompa, P.; Farkas, A.
The calpain-system of Drosophila melanogaster: coming of age
Bioessays
26
1088-1096
2004
Drosophila melanogaster (Q9VT65), Drosophila melanogaster
brenda
Alexa, A.; Bozky, Z.; Farkas, A.; Tompa, P.; Friedrich, P.
Contribution of distinct structural elements to activation of calpain by Ca2+ ions
J. Biol. Chem.
279
20118-20126
2004
Drosophila melanogaster (Q9VT65)
brenda
Kovacs, L.; Alexa, A.; Klement, E.; Kokai, E.; Tantos, A.; Gogl, G.; Sperka, T.; Medzihradszky, K.F.; Toezser, J.; Dombradi, V.; Friedrich, P.
Regulation of calpain B from Drosophila melanogaster by phosphorylation
FEBS J.
276
4959-4972
2009
Drosophila melanogaster (Q9VT65), Drosophila melanogaster
brenda
Osman, D.; Gobert, V.; Ponthan, F.; Heidenreich, O.; Haenlin, M.; Waltzer, L.
A Drosophila model identifies calpains as modulators of the human leukemogenic fusion protein AML1-ETO
Proc. Natl. Acad. Sci. USA
106
12043-12048
2009
Drosophila melanogaster
brenda